Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Dysgeusia 2Warts 1Uterine Cervical Neoplasms 1Stomatitis 1Stomach Neoplasms 1Radiation-Induced Mucositis 1Radiation Injuries 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Mouth Neoplasms 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Atypical Squamous Cells of the Cervix 1

Interventions

Sorafenib 202lenvatinib 129Bevacizumab 124Nivolumab 85pembrolizumab 72atezolizumab 72Radiosurgery 71durvalumab 63Oxaliplatin 59sintilimab 57Fluorouracil 54Doxorubicin 44tislelizumab 43apatinib 43Leucovorin 40tremelimumab 37camrelizumab 37Radiofrequency Ablation 37Radiotherapy 36Magnetic Resonance Spectroscopy 32Capecitabine 30regorafenib 29Folfox protocol 29Cisplatin 28cabozantinib 26Hepatectomy 26Gemcitabine 26Cyclophosphamide 26Ipilimumab 25toripalimab 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Hepatocellular × Zinc Sulfate × Clear all
NCT03819088 2025-10-09

Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer

Emory University

Phase NA Completed
17 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡